5:35 PM
 | 
Dec 22, 2011
 |  BC Extra  |  Financial News

AuraSense closes series B round

Gene therapy company AuraSense Therapeutics LLC (Evanston, Ill.) raised an undisclosed amount in a series B round. Investors included Abbott Laboratories...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >